You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 5, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Zhida Fu1, Yinghui Fang2, Dapeng Wang3
1Aviation General Hospital (Thoracic Surgery), Chaoyang, Beijing, China.
Personalized adjuvant radiation therapy using radionuclide imaging improves esophageal cancer treatment by increasing tumor control and reducing side effects. This precision approach enhances outcomes after surgery.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: